Description: Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.
Home Page: www.medios.ag
Heidestrasse 9
Berlin,
10557
Germany
Phone:
49 30 232 5668 00
Officers
Name | Title |
---|---|
Mr. Matthias Gaertner | CEO & Chairman of the Exec. Board |
Mr. Falk Neukirch | CFO & Member of Exec. Board |
Mr. Christoph Prußeit | Chief Innovation Officer & Member of Exec. Board |
Ms. Mi-Young Miehler | COO & Member of Exec. Board |
Claudia Nickolaus | Head of Investor & PR |
Exchange: XETRA
Country: DE : Germany
Currency: Euro (€)
Forward PE: | 0 |
---|---|
Trailing PE: | 38.3404 |
Price-to-Book MRQ: | 1.0855 |
Price-to-Sales TTM: | 0.2788 |
IPO Date: | |
Fiscal Year End: | December |
Full Time Employees: | 514 |